Abstract:Background: Lobectomy for lung cancer often presents a lot of potentially severe complications after surgery for patients. Enhanced Recovery After Surgery (ERAS) is a program to improve unexpected events. When implementing ERAS, there needs to be evidence of relevant factors that prolong hospital stays to encourage the participation of medical staff and leaders. This study is to determine the length of hospital stay (LOS) and its related factors after surgery in patients undergoing lobectomy for non-small cell lung cancer. Methods: A descriptive retrospective study was conducted on 99 patients undergoing lobectomy for non-small cell lung cancer at University Medical Center Ho Chi Minh City. Data were extracted from a computerized database of patients who were hospitalized for lobectomy in the treatment of non-small cell lung cancer from January 2018 to December 2021. The primary outcome was the postoperative LOS. Results: Median postoperative LOS was 5.2 days (interquartile range 4.8 to 6.8 days). The complication rate was 19.2%, of which Clavien-Dindo II accounted for the highest at 9.1%. The 30-day readmission rate was 13.1%. The median of LOS in the current cigarette smoker's group was 1.9 days higher than the never-cigarette smoker's group and 1.5 days higher than the former cigarette smokers (p<0.001). Tumor-nodes-metastasis (TNM) stage III showed the highest LOS compared to other stages (p=0.029). Open surgery and thoracoscopic conversion to open showed postoperative LOS about two days longer than thoracoscopic surgery (p<0.001). Performing muscle relaxation and early extubation, multimodal analgesia reduced postoperative LOS by 1.6 days (p<0.001), and preoperative physical therapy and early physical therapy at recovery reduced postoperative LOS by 1.3 days (p<0.001). There was a strong positive correlation between the duration of endotracheal retention, duration of thoracic drainage, amount of blood loss, and postoperative LOS (R>0.5, p<0.001). The duration of the Post-Anesthesia Care Unit and fasting time after surgery showed an average positive correlation with postoperative LOS (0.3<R<0.5, p<0.001). Preoperative fasting time had a weak positive correlation with postoperative LOS (R=0.265, p=0.008). Conclusions: The median postoperative LOS was 5.2 days, and more than half of patients stayed in the hospital for over five days. Some factors affect the LOS, including current cigarette smokers, TNM stage, surgical approaches, some care processes such as early extubation, multimodal pain relief, physical therapy, vomiting, duration of thoracic drainage, amount of blood loss, duration of Post-Anesthesia Care Unit (hours), duration of thoracic drainage (days), preoperative and postoperative fasting time (hours). The study results help propose many changes in perioperative care for patients undergoing lung cancer surgery.

Early discharge on postoperative day 1 following lobectomy for stage I non-small-cell lung cancer is safe in high-volume surgical centres: a national cancer database analysis.

Early Discharge After Lobectomy for Lung Cancer Does Not Equate to Early Readmission

The safety and feasibility of same-day discharge for the management of patients undergoing pulmonary lobectomy

Time Trend of Mediastinal Lymph Node Dissection in Stage IA Non-Small Cell Lung Cancer Patient Who Undergo Lobectomy: a Retrospective Study of Surveillance, Epidemiology, and End Results (SEER) Database

Sublobar Resection Is Associated With Better Perioperative Outcomes In Elderly Patients With Clinical Stage I Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study

Rapid discharge after anatomic lung resection: Is ambulatory surgery for early lung cancer possible?

Analysis for Discharge Within 2 Days after Thoracoscopic Anatomic Lung Cancer Surgery.

Effects of Intraoperative Fluid Management on Postoperative Outcomes after Lobectomy.

Factors associated with safe and successful postoperative day 1 discharge after lung operations: a systematic review and meta-analysis

Sublobectomy Versus Lobectomy for Long-Term Survival Outcomes of Early-Stage Non-Small Cell Lung Cancer with a Tumor Size ≤2 Cm Accompanied by Visceral Pleural Invasion: a SEER Population-Based Study

Lobectomy with Lymph Node Dissection Benefits N3 Stage Non-Small Cell Lung Cancer Patients: A Population-Based Study

Impact of perioperative fluid overload on the occurrence of postoperative pulmonary complications following lobectomy

Prognostic Impact of Lymphadenectomy on Outcomes of Sublobar Resection for Stage IA Non–small Cell Lung Cancer ≤2 Cm

Optimizing Lung Cancer Surgery in the Elderly: Sublobar Resection Versus Lobectomy for Early-Stage Non-Small Cell Lung Cancer Patients Aged 80 and Above.

Clinical Analysis of 100 Consecutive Completely Thoracoscopic Lobectomy

[Classification and Risk-factor Analysis of Postoperative Cardio-pulmonary Complications after Lobectomy in Patients with Stage I Non-small Cell Lung Cancer]

Survival Rates after Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.

Discussion of the experience and improvement of an enhanced recovery after surgery procedure for minimally invasive lobectomy: a cohort study

Implication of a novel postoperative recovery protocol to increase day 1 discharge rate after anatomic lung resection

Length of Postoperative Hospital Stay and Related Factors After Lobectomy for Lung Cancer: A Pre-enhanced Recovery After Surgery (ERAS) Single Center Assessment

Early Postoperative Patient-Reported Outcomes After Thoracoscopic Segmentectomy Versus Lobectomy for Small-Sized Peripheral Non-small-cell Lung Cancer